Molecular Mechanisms of Inflammation and Their Role in the Development of Chronic Diseases: A Narrative Review
DOI:
https://doi.org/10.64048/hir.v2n1.007Keywords:
Inflammation, Chronic Inflammation, Molecular Mechanisms, NF-κB, NLRP3 Inflammasome, Cytokines, Chronic DiseaseAbstract
Inflammation is a fundamental and protective biological response, yet when it becomes chronic and unresolved it emerges as a central driver in the pathogenesis of many of the most burdensome human diseases. The molecular machinery governing the inflammatory response, when persistently activated, contributes to progressive tissue injury and organ dysfunction. This narrative review comprehensively examines the molecular mechanisms of inflammation and clarifies how these mechanisms participate in the development of chronic diseases. The cellular sensing of danger through pattern recognition receptors, the activation of the nuclear factor-κB (NF-κB) signalling pathway, the assembly of the NLRP3 inflammasome, and the resulting production of pro-inflammatory cytokines and lipid mediators are described in an integrated manner. The distinction between self-limiting acute inflammation and persistent low-grade chronic inflammation is emphasized, since the failure of resolution is now recognized as a key pathological event. The review further details how these molecular processes converge on the pathogenesis of atherosclerosis and cardiovascular disease, type 2 diabetes and metabolic dysfunction, cancer, neurodegenerative disorders, and autoimmune conditions. The role of specialized pro-resolving mediators and the therapeutic opportunities arising from targeting inflammatory pathways are also considered. By synthesizing current mechanistic understanding with its clinical consequences, this review provides both a conceptual framework and a practical reference for researchers and clinicians. In sum, the work positions chronic inflammation as a unifying mechanism across diverse diseases and underscores the value of resolution-based and pathway-specific strategies for prevention and treatment.
Downloads
References
BROZ, P. & DIXIT, V. M. 2016. Inflammasomes: mechanism of assembly, regulation and signalling. Nature Reviews Immunology, 16, 407-420. https://doi.org/10.1038/nri.2016.58
CHEN, L., DENG, H., CUI, H., ET AL. 2018. Inflammatory responses and inflammation-associated diseases in organs. Oncotarget, 9, 7204-7218. https://doi.org/10.18632/oncotarget.23208
COUSSENS, L. M. & WERB, Z. 2002. Inflammation and cancer. Nature, 420, 860-867. https://doi.org/10.1038/nature01322
DONATH, M. Y. & SHOELSON, S. E. 2011. Type 2 diabetes as an inflammatory disease. Nature Reviews Immunology, 11, 98-107. https://doi.org/10.1038/nri2925
FURMAN, D., CAMPISI, J., VERDIN, E., ET AL. 2019. Chronic inflammation in the etiology of disease across the life span. Nature Medicine, 25, 1822-1832. https://doi.org/10.1038/s41591-019-0675-0
GRIVENNIKOV, S. I., GRETEN, F. R. & KARIN, M. 2010. Immunity, inflammation, and cancer. Cell, 140, 883-899. https://doi.org/10.1016/j.cell.2010.01.025
HENEKA, M. T., CARSON, M. J., EL KHOURY, J., ET AL. 2015. Neuroinflammation in Alzheimer's disease. The Lancet Neurology, 14, 388-405. https://doi.org/10.1016/S1474-4422(15)70016-5
HOTAMISLIGIL, G. S. 2006. Inflammation and metabolic disorders. Nature, 444, 860-867. https://doi.org/10.1038/nature05485
HOTAMISLIGIL, G. S. 2017. Inflammation, metaflammation and immunometabolic disorders. Nature, 542, 177-185. https://doi.org/10.1038/nature21363
KAWAI, T. & AKIRA, S. 2010. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nature Immunology, 11, 373-384. https://doi.org/10.1038/ni.1863
LAWRENCE, T. 2009. The nuclear factor NF-κB pathway in inflammation. Cold Spring Harbor Perspectives in Biology, 1, a001651. https://doi.org/10.1101/cshperspect.a001651
LIBBY, P. 2012. Inflammation in atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology, 32, 2045-2051. https://doi.org/10.1161/ATVBAHA.108.179705
LIU, T., ZHANG, L., JOO, D. & SUN, S. C. 2017. NF-κB signaling in inflammation. Signal Transduction and Targeted Therapy, 2, 17023. https://doi.org/10.1038/sigtrans.2017.23
MEDZHITOV, R. 2008. Origin and physiological roles of inflammation. Nature, 454, 428-435. https://doi.org/10.1038/nature07201
MEDZHITOV, R. 2010. Inflammation 2010: new adventures of an old flame. Cell, 140, 771-776. https://doi.org/10.1016/j.cell.2010.03.006
NATHAN, C. & DING, A. 2010. Nonresolving inflammation. Cell, 140, 871-882. https://doi.org/10.1016/j.cell.2010.02.029
SERHAN, C. N. 2014. Pro-resolving lipid mediators are leads for resolution physiology. Nature, 510, 92-101. https://doi.org/10.1038/nature13479
SWANSON, K. V., DENG, M. & TING, J. P. 2019. The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nature Reviews Immunology, 19, 477-489. https://doi.org/10.1038/s41577-019-0165-0
TABAS, I. & GLASS, C. K. 2013. Anti-inflammatory therapy in chronic disease: challenges and opportunities. Science, 339, 166-172. https://doi.org/10.1126/science.1230720
TAKEUCHI, O. & AKIRA, S. 2010. Pattern recognition receptors and inflammation. Cell, 140, 805-820. https://doi.org/10.1016/j.cell.2010.01.022
Downloads
Published
Data Availability Statement
No data were used in the research described in this article.
Issue
Section
License
Copyright (c) 2026 Jihad Haji Saleh (Author)

This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles published in Health Innovation Reports are licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This means anyone is free to share and adapt the work, provided proper attribution is given to the original authors and source.
